2型心肌梗死:JACC本周综述
2型心肌梗死(T2MI)是在无急性动脉粥样硬化斑块破裂的情况下,因心肌氧供需失衡所致的心肌梗死,需有心肌缺血的临床证据方可诊断。随着肌钙蛋白检测敏感性提高,T2MI诊断日益增多,且与不良短期和长期预后相关。由于病因和触发因素异质,最佳管理策略数据有限,需个体化诊疗,主要障碍是缺乏可操作且高可重复性的统一定义。
要点
- 诊断T2MI需有心肌缺血的临床证据,并排除急性动脉粥样硬化血栓性斑块破裂。
- 肌钙蛋白检测敏感性提高使T2MI诊断增多,且与不良短期和长期预后相关。
- T2MI病因异质,需个体化诊疗,目前缺乏统一定义和最佳管理策略数据。
核心结论
- T2MI是氧供需失衡所致心肌梗死,需临床缺血证据诊断,预后不良且管理需个体化。
研究设计与样本
- 综述类文献,检索范围未明确报告。
主要发现
- 肌钙蛋白检测敏感性提高使T2MI诊断日益增多。
- T2MI与不良短期和长期预后相关。
- T2MI病因和触发因素异质,最佳管理策略数据有限。
关键数值与推荐
- 诊断T2MI需有心肌缺血的临床证据。
- T2MI需在无急性动脉粥样硬化斑块破裂的情况下诊断。
临床怎么用
- 临床需个体化诊疗T2MI患者,并识别其病因和触发因素。
- 诊断T2MI时应确保有心肌缺血的临床证据。
局限性
- 缺乏可操作且高可重复性的统一定义。
- 最佳管理策略数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute myocardial infarction (MI) can occur from increased myocardial oxygen demand and/or reduced supply in the absence of acute atherothrombotic plaque disruption; a condition called type 2 myocardial infarction (T2MI). As with any MI subtype, there must be clinical evidence of myocardial ischemia to make the diagnosis. This condition is increasingly diagnosed due to the increasing sensitivity of cardiac troponin assays and is associated with adverse short-term and long-term prognoses. Limited data exist defining optimal management strategies because T2MI is a heterogeneous entity with varying etiologies and triggers. Thus, these patients require individualized care. A major barrier is the absence of a uniform definition that can be operationalized with high reproducibility. This document provides a synthesis of the data about T2MI to assist clinicians' understanding of its pathobiology, when to deploy the diagnosis, and its associated treatments. It also clarifies prognosis, identifies gaps in knowledge, and provides recommendations for moving forward.
引用
- Sandoval Y, Jaffe AS. Type 2 Myocardial Infarction: JACC Review Topic of the Week. J Am Coll Cardiol. 2019. PMID: 30975302. doi:10.1016/j.jacc.2019.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。